Understanding the Role of Tumor Stem Cells in Glioblastoma Multiforme: a Review Article

Overview

Journal J Neurooncol

Publisher Springer

Date 2010 Sep 21

PMID 20853017

Citations 11

Authors

Aalya Fatoo

Michael J Nanaszko

Baxter B Allen

Christina L Mok

Elena N Bukanova

Robel Beyene

Jennifer A Moliterno

John A Boockvar

Affiliations

Soon will be listed here.

Abstract

It has been hypothesized that cancer stem cells (CSC) may account for the pathogenesis underlying various tumors, including GBM. Markers of these CSCs can be potentially used as therapeutic targets. In this review, we discuss the most recent information regarding CSCs, their molecular biology and their potential role in GBM.

Citing Articles

A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas.

Kumthekar P, Grimm S, Chandler J, Mehta M, Marymont M, Levy R J Neurooncol. 2017; 133(3):589-594.

PMID: 28510787 DOI: 10.1007/s11060-017-2469-x.

Transcriptional profiling of dividing tumor cells detects intratumor heterogeneity linked to cell proliferation in a brain tumor model.

Endaya B, Lam P, Meedeniya A, Neuzil J Mol Oncol. 2015; 10(1):126-37.

PMID: 26388584 PMC: 5528932. DOI: 10.1016/j.molonc.2015.09.001.

A novel berbamine derivative inhibits cell viability and induces apoptosis in cancer stem-like cells of human glioblastoma, via up-regulation of miRNA-4284 and JNK/AP-1 signaling.

Yang F, Nam S, Brown C, Zhao R, Starr R, Ma Y PLoS One. 2014; 9(4):e94443.

PMID: 24732116 PMC: 3986211. DOI: 10.1371/journal.pone.0094443.

Akt and c-Myc induce stem-cell markers in mature primary p53⁻/⁻ astrocytes and render these cells gliomagenic in the brain of immunocompetent mice.

Radke J, Bortolussi G, Pagenstecher A PLoS One. 2013; 8(2):e56691.

PMID: 23424671 PMC: 3570527. DOI: 10.1371/journal.pone.0056691.

The EphA2 receptor drives self-renewal and tumorigenicity in stem-like tumor-propagating cells from human glioblastomas.

Binda E, Visioli A, Giani F, Lamorte G, Copetti M, Pitter K Cancer Cell. 2012; 22(6):765-80.

PMID: 23238013 PMC: 3922047. DOI: 10.1016/j.ccr.2012.11.005.

References

Bao S, Wu Q, McLendon R, Hao Y, Shi Q, Hjelmeland A . Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006; 444(7120):756-60. DOI: 10.1038/nature05236. View

Okano H, Kawahara H, Toriya M, Nakao K, Shibata S, Imai T . Function of RNA-binding protein Musashi-1 in stem cells. Exp Cell Res. 2005; 306(2):349-56. DOI: 10.1016/j.yexcr.2005.02.021. View

Frank J, Miller B, Arbab A, Zywicke H, Jordan E, Lewis B . Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology. 2003; 228(2):480-7. DOI: 10.1148/radiol.2281020638. View

Kelly J, Stechishin O, Chojnacki A, Lun X, Sun B, Senger D . Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens. Stem Cells. 2009; 27(8):1722-33. DOI: 10.1002/stem.98. View

Gilbertson R, Rich J . Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat Rev Cancer. 2007; 7(10):733-6. DOI: 10.1038/nrc2246. View

Wang J, Wang X, Jiang S, Lin P, Zhang J, Wu Y . Partial biological characterization of cancer stem-like cell line (WJ(2)) of human glioblastoma multiforme. Cell Mol Neurobiol. 2008; 28(7):991-1003. PMC: 11515052. DOI: 10.1007/s10571-008-9273-2. View

Friedman H, Prados M, Wen P, Mikkelsen T, Schiff D, Abrey L . Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol. 2009; 27(28):4733-40. DOI: 10.1200/JCO.2008.19.8721. View

Xu Q, Yuan X, Liu G, Black K, Yu J . Hedgehog signaling regulates brain tumor-initiating cell proliferation and portends shorter survival for patients with PTEN-coexpressing glioblastomas. Stem Cells. 2008; 26(12):3018-26. DOI: 10.1634/stemcells.2008-0459. View

Vredenburgh J, Desjardins A, Herndon 2nd J, Marcello J, Reardon D, Quinn J . Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol. 2007; 25(30):4722-9. DOI: 10.1200/JCO.2007.12.2440. View

10.

Kanamori M, Kawaguchi T, Nigro J, Feuerstein B, Berger M, Miele L . Contribution of Notch signaling activation to human glioblastoma multiforme. J Neurosurg. 2007; 106(3):417-27. DOI: 10.3171/jns.2007.106.3.417. View

11.

Aghi M, Chiocca E . Phase ib trial of oncolytic herpes virus G207 shows safety of multiple injections and documents viral replication. Mol Ther. 2009; 17(1):8-9. PMC: 2834994. DOI: 10.1038/mt.2008.275. View

12.

Wang J, Wakeman T, Lathia J, Hjelmeland A, Wang X, White R . Notch promotes radioresistance of glioma stem cells. Stem Cells. 2009; 28(1):17-28. PMC: 2825687. DOI: 10.1002/stem.261. View

13.

Kinoshita Y, Kamitani H, Mamun M, Wasita B, Kazuki Y, Hiratsuka M . A gene delivery system with a human artificial chromosome vector based on migration of mesenchymal stem cells towards human glioblastoma HTB14 cells. Neurol Res. 2009; 32(4):429-37. DOI: 10.1179/174313209X455718. View

14.

Buckner J, Brown P, ONeill B, Meyer F, Wetmore C, Uhm J . Central nervous system tumors. Mayo Clin Proc. 2007; 82(10):1271-86. DOI: 10.4065/82.10.1271. View

15.

Loilome W, Joshi A, ap Rhys C, Piccirillo S, Vescovi A, Angelo V . Glioblastoma cell growth is suppressed by disruption of Fibroblast Growth Factor pathway signaling. J Neurooncol. 2009; 94(3):359-66. DOI: 10.1007/s11060-009-9885-5. View

16.

Hu T, Liu S, Breiter D, Wang F, Tang Y, Sun S . Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis. Cancer Res. 2008; 68(16):6533-40. DOI: 10.1158/0008-5472.CAN-07-6642. View

17.

Uchida N, Buck D, He D, Reitsma M, Masek M, Phan T . Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A. 2000; 97(26):14720-5. PMC: 18985. DOI: 10.1073/pnas.97.26.14720. View

18.

McCord A, Jamal M, Shankavaram U, Shankavarum U, Lang F, Camphausen K . Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro. Mol Cancer Res. 2009; 7(4):489-97. PMC: 6290460. DOI: 10.1158/1541-7786.MCR-08-0360. View

19.

Rodrigues J, Gonzalez G, Zhang L, Ibrahim G, Kelly J, Gustafson M . Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties. Neuro Oncol. 2010; 12(4):351-65. PMC: 2940603. DOI: 10.1093/neuonc/nop023. View

20.

Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin N . Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell. 2006; 9(5):391-403. DOI: 10.1016/j.ccr.2006.03.030. View